Wegovy’s Heart Benefits Boost Novo Nordisk’s Market Edge

New trial data reveals Wegovy’s edge in reducing heart risks, but can Novo Nordisk overcome U.S. market hurdles? Click to...

01/09/2025

2 views

China’s Biotech Boom Challenges U.S. Pharma Dominance

China’s biotech is skyrocketing, rivaling U.S. giants with cutting-edge drugs and billion-dollar deals. Can they overtake the West in innovation?...

15/07/2025

2 views

Eli Lilly's latest acquisition spree hints at a future beyond obesity drugs. From gene-editing to pain relief, what’s next for...

17/06/2025

0 views

Pfizer’s weight loss pill was scrapped after a liver scare. What does this mean for obesity drugs and biotech stocks?...

14/04/2025

0 views